WVP
TVTX icon

Worth Venture Partners’s Travere Therapeutics TVTX Stock Holding History

Worth Venture Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-42,800
Closed -$12K – 137
2020
Q2 		$12K Sell
42,800
-29,000
-40% -$462K 0.01% 114
2020
Q1 		$106K Buy
71,800
+50,300
+234% +$757K 0.07% 87
2019
Q4 		$13K Sell
21,500
-85,900
-80% -$1.1M 0.01% 82
2019
Q3 		$26K Sell
107,400
-78,400
-42% -$1.3M 0.01% 88
2019
Q2 		$289K Buy
185,800
+166,621
+869% +$3.29M 0.16% 57
2019
Q1 		$84K Buy
+19,179
New +$424K 0.05% 73

Other funds holding TVTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return